India's Largest Database on New Projects
Aurobindo gets USFDA nod for Alprazolam
9 June 2011: Aurobindo Pharma on 8 June 2011 has received final approval from the US health regulator to manufacture and market tablets of Alprazolam, a central nervous system drug, in the American market.
The company has received final approval from the US Food and Drug Administration (USFDA) to manufacture and market Alprazolam extended-release tablets in strengths of 0.5 mg, 1 mg, 2 mg and 3mg.
Alprazolam extended-release tablets are the generic equivalent of Xanax XR tablets. The tablets are indicated for treating panic disorders and fall under the central nervous system (CNS) segment.
Source: Source: Hindu Business Line